AKT1 and metabolic dysfunction-associated steatotic liver disease: In HCC induced by non‐alcoholic fatty liver disease (NAFLD), terbinafine promotes SQLE degradation via autophagy and subsequently restores PTEN expression, effectively inhibiting the AKT/mTOR signaling pathway [174].